recombinant mouse complement component c5a (R&D Systems)
Structured Review

Recombinant Mouse Complement Component C5a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 57 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+c5a/Recombinant+Mouse+Complement+Component+C5a+Protein/bio_rxiv__64898__2026__04__07__716973-156-5-10
Average 93 stars, based on 57 article reviews
Images
1) Product Images from "SARM1 is required for macrophage immunophenotype switching that is essential for nerve repair"
Article Title: SARM1 is required for macrophage immunophenotype switching that is essential for nerve repair
Journal: bioRxiv
doi: 10.64898/2026.04.07.716973
Figure Legend Snippet: ( A ) Representative still images from live cell imaging sequences following a 2D scratch assay of WT and Sarm1-/- stimulated Mɸ. t=0 is immediately after the scratch and t=48 hours is 48 hours post-scratch. Scratch boundaries are indicated by yellow dashed lines. Scale bar = 300µm. ( B,C ) Quantification of the relative wound density of WT ( B ) or Sarm1-/- ( C ) Mɸ cultures after the scratch assay in A represented as a percentage of t=0. N=3 biological replicates. Error = SEM. *p<0.05; **p<0.01; ***p<0.005; letters (a,b,c) p<0.05. by two-way repeated measures ANOVA with Dunnett post-hoc test. Blue asterisk = mCSF compared to t=0. Green asterisk = IL-4 compared to t=0. Orange asterisk = LPS compared to t=0. a = mCSF compared to IL-4; b = mCSF compared to LPS; c = mCSF compared to IFNɣ conditions at indicated timepoints. ( D ) Representative still images from live cell imaging sequences following a 3D invasion assay in Matrigel of WT and Sarm1-/- stimulated Mɸ. t=0 immediately after the scratch and t=48 hours is 48 hours post-scratch. Scratch boundaries are indicated by yellow dashed lines. Scale bar = 300µm. ( E ) Quantification of the relative wound density of the invasion assay without C5a added (top) and with C5a added as a chemoattractant (bottom) represented as a percentage of t=0. N=2-4 biological replicates. Error = SEM. Letters (b,c) p<0.05; **p<0.01; ***p<0.005; ****p<0.001 by two-way ANOVA, main effects model with Tukey post-hoc test after simple linear regression model indicated slopes were not different. Wildtype Mɸ + C5a main effects could not be calculated because slopes were significantly different. Orange asterisk = LPS compared to t=0. b = mCSF compared to LPS; c = mCSF compared to IFNɣ conditions at indicated timepoints. ( F ) Representative images of F4/80 (green) positive Mɸ stained for Oil Red O lipids (magenta) following a myelin challenge assay. No clearance indicates a 24 hour myelin treatment and clearance indicates 24 hours of myelin treatment followed by myelin removal for 24 hours. Scale bar = 100µm. ( G ) Quantification of OilRedO intensity per Mɸ (normalized to Mɸ cell area). N = 3 biological replicates and each data point = 1 Mɸ. Mean +/- SEM is shown. Outliers were removed with ROUT Q=1. **p<0.01; ***p<0.005; ****p<0.001 by Kruskal-Wallis test with Dunn’s correction for multiple comparisons. Black asterisk = WT to Sarm1-/- comparisons. Purple asterisk = Sarm1-/- to Sarm1-/- comparisons. Blue asterisk = WT to WT comparisons.
Techniques Used: Live Cell Imaging, Wound Healing Assay, Invasion Assay, Staining
Related Articles
Recombinant:Article Title: C5a–C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms Article Snippet: NIH3T3 cells were treated with each dose of the selective mTOR (mammalian target of rapamycin) inhibitor Torin1 (IC 50 ; 2.0 nM, lot: 3143151, #475991, Sigma-Aldrich) at the indicated dose and time period. .. PMA-primed U937 cells were treated with each dose of Article Title: Eculizumab treatment alters the proteometabolome beyond the inhibition of complement Article Snippet: .. For stimulation with C5a, we used Article Title: Identification of immune checkpoints in COVID-19 Article Snippet: .. Then, 18 nM of human Article Title: C3a Mediates Endothelial Barrier Disruption in Brain-Derived, but Not Retinal, Human Endothelial Cells Article Snippet: .. Following a 17 h growth phase, HBMEC and HREC were subjected to recombinant C3a (R&D Systems, Minneapolis, MN, USA, #3677-C3-025) or Article Title: TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function Article Snippet: Adult Microglia Transwell Migration assay – Microglia were plated in complete media at 5000 cells/well in transwell plates (Essen Bioscience) pre-coated with 20 g/ml Protein G (Life Technologies) and 5 g/ml I-CAM (Life Technologies). .. Transwells were placed in reservoir plates containing by guest on A pril 14, 2018 http://w w w .jbc.org/ D ow nloaded from 200 l complete media with 1 g/ml Article Title: C3a Mediates Endothelial Barrier Disruption in Brain-Derived, but Not Retinal, Human Endothelial Cells. Article Snippet: .. Following a 17 h growth phase, HBMEC and HREC were subjected to recombinant C3a (R&D Systems, Minneapolis, MN, USA, #3677-C3-025) or Article Title: Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy. Article Snippet: Cell culture Human immortalized proximal tubule epithelial HK-2 cells (American Type Culture Collection, Manassas, VA, USA) were cultured in Dulbecco’s modified Eagle medium/nutrient mixture F-12, supplemented with penicillin (100 IU/mL), streptomycin (100mg/mL) and 10% foetal bovine serum (Invitrogen, Carsbad, CA, USA) at 37 C in 5% carbon dioxide atmosphere. .. Growtharrested HK-2 cells were stimulated with 50 ng other:Article Title: Glioblastoma Cell–Derived lncRNA-Containing Exosomes Induce Microglia to Produce Complement C5, Promoting Chemotherapy Resistance Article Snippet: TMZ (Selleck, cat. 85622-93-1) was added to glioma culture medium (CM) at a concentration of 200 mmol/L for 24 hours in vitro and 60 mg/kg via intraperitoneal injection in vivo. |


